Malignant tumor of breast (disorder)

EMERALD - A window of opportunity study to assess the biological effect of enobosarm in oestrogen receptor positive, androgen receptor positive early breast cancer

Year Started: 2017

Clinical trial samples from the EMERALD study. Samples include blood (processed to plasma and serum) and tissue (frozen and FFPE).



Access:
Closed to access
Type:
Clinical Trial
Status:
In progress
Consent restrictions:
Other animal work restriction, Xenograft restriction


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) Under -85°C N/A Affected 11 - 25%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Whole blood -60°C to -85°C N/A Non-affected 51 - 75%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Non-affected 51 - 75%


Female

Adult (> 40 years)

1 - 10 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Non-affected 51 - 75%